Cost-Effectiveness of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data from the PROVAR+ Study: Cost-effectiveness of RHD screening in Brazil
By: Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento and On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators
References
- Watkins DA, Johnson CO, Colquhoun SM, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990–2015. New England Journal of Medicine. 2017; 377(8): 713–22. DOI: 10.1056/NEJMoa1603693
- Meira ZMA, Goulart EMA, Colosimo EA, Mota CCC. Long-term Follow-up of Rheumatic Fever and Predictors of Severe Rheumatic Valvar Disease in Brazilian Children and Adolescents. Heart. 2005; 91(8): 1019–22. DOI: 10.1136/hrt.2004.042762
- Nascimento BR, Beaton AZ, Nunes MCP, et al. Echocardiographic Prevalence of Rheumatic Heart Disease in Brazilian Schoolchildren: Data from the PROVAR Study. International Journal of Cardiology. 2016; 219: 439–45. DOI: 10.1016/j.ijcard.2016.06.088
- Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilário MO. Resource Utilization and Cost of Rheumatic Fever. Journal of Rheumatology. 2001; 28(6): 1394–7.
- Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic Heart Disease. Lancet. 2012; 379(9819): 953–64. DOI: 10.1016/S0140-6736(11)61171-9
- ARF RHD Guideline. 2016: 55–8.
- Barbosa PJB, Mülle RE. Diretrizes Brasileiras para diagnóstico, tratamento e prevenção da febre reumática. Arq Bras Cardiol. 2009; 93(Suppl 4): 127–47.
- Roberts K, Cannon J, Atkinson D, et al. Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost–Utility Analysis. Journal of the American Heart Association. 2017; 6(3):
e004515 . DOI: 10.1161/JAHA.116.004515 - Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the Primary Prevention of Acute Rheumatic Fever: A Meta-Analysis. BMC Cardiovascular Disorders. 2005; 5(1): 11. DOI: 10.1186/1471-2261-5-11
- Nascimento BR, Sable C, Nunes MCP, et al. Comparison Between Different Strategies of Rheumatic Heart Disease Echocardiographic Screening in Brazil: Data From the PROVAR (Rheumatic Valve Disease Screening Program) Study. Journal of the American Heart Association. 2018; 7(4). DOI: 10.1161/JAHA.117.008039
- Sato RC, Zouain DM. Markov Models in health care. Einstein (Sao Paulo). 2010; 8(3): 376–9. DOI: 10.1590/s1679-45082010rb1567
- Reményi B, Wilson N, Steer A, et al. World Heart Federation criteria for Echocardiographic Diagnosis of Rheumatic Heart Disease: an Evidence-Based. Guideline. Nature Reviews Cardiology. 2012; 9(5): 297–309. DOI: 10.1038/nrcardio.2012.7
- Brandner A, Schreiweis B, Aguduri LS, et al.
The Patient Portal of the Personal Cross-Enterprise Electronic Health Record (PEHR) in the Rhine-Neckar-Region . In: Hoerbst A, Hackl WO, De Keizer N (eds.), Exploring Complexity in Health: An Interdisciplinary Systems Approach, 157–61. 228: IOS Press; 2016. - XE Currency Converter – Live Rates. 1145 Nicholson Rd, Suite 200 Newmarket ON, L3Y 9C3 Canada: XE.com. Available from:
http://www.xe.com/currencyconverter/ . - XE Currency Converter – Live Rates. Newmarket, ON, Canada: XE.com; 2017. Available from:
http://www.xe.com/currencyconverter/ . - Sisbacen®. Calculadora do Cidadão Brasília: Banco Central do Brasil; 2017. Available from:
https://www3.bcb.gov.br/CALCIDADAO/publico/corrigirPorIndice.do?method=corrigirPorIndice . - Ribeiro RA, Mello RGB, Melchior R, et al. Annual Cost of Ischemic Heart Disease in Brazil: Public and Private Perspective. Arquivos Brasileiros de Cardiologia. 2005; 85(1): 3–8.
- Network GBoDC. Global Burden of Disease Study 2016 (GBD 2016) Disability Weights. Seattle, United States: Institute for Health Metrics and Evaluation (IHME); 2017.
- Bradley-Hewitt T, Dantin A, Ploutz M, et al. The Impact of Echocardiographic Screening for Rheumatic Heart Disease on Patient Quality of Life. The Journal of Pediatrics. 2016; 175: 123–9. DOI: 10.1016/j.jpeds.2016.04.087
- Szwarcwald CL, Corrêa da Mota J, Damacena GN, Sardinha Pereira TG. Health inequalities in Rio de Janeiro, Brazil: Lower healthy life expectancy in socioeconomically disadvantaged areas. American Journal of Public Health. 2011; 101(3): 517–23. DOI: 10.2105/AJPH.2010.195453
- Baltussen RM, Adam T, Tan-Torres Edejer T, et al. Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis; 2003.
- Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database of Systematic Reviews. 2002; 3. DOI: 10.1002/14651858.CD002227
- Soarez PCD, Novaes HMD. Cost-Effectiveness Thresholds and the Brazilian Unified National Health System. Cadernos de Saúde Pública. 2017; 33(4):
e00040717 . - Prado CCL. A adoção do limite custo-efetividade na incorporação de tecnologias no SUS–o que se pode esperar. Revista Eletrônica Gestão e Saúde. 2015; 4: 3127–49. DOI: 10.18673/gs.v6i4.22103
- Cannon J, Roberts K, Milne C, Carapetis JR. Rheumatic Heart Disease Severity, Progression and Outcomes: A Multi-State Model. Journal of the American Heart Association. 2017; 6(3). DOI: 10.1161/JAHA.116.003498
- Beaton A, Aliku T, Dewyer A, et al. Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome. Circulation. 2017; 136(23): 2233–44. DOI: 10.1161/CIRCULATIONAHA.117.029936
- Brant L, Nascimento B, Passos V, et al. Variations and particularities in cardiovascular disease mortality in Brazil and Brazilian states in 1990 and 2015: Estimates from the Global Burden of Disease. Rev Bras Epidemiol. 2017; 20(suppl 1): 116–28.
- Okello E, Longenecker CT, Beaton A, Kamya MR, Lwabi P. Rheumatic heart disease in Uganda: Predictors of morbidity and mortality one year after presentation. BMC Cardiovascular Disorders. 2017; 17(1): 20. DOI: 10.1186/s12872-016-0451-8
- Zachariah JP, Samnaliev M. Echo-based screening of rheumatic heart disease in children: A cost-effectiveness Markov model. Journal of Medical Economics. 2015; 18(6): 410–9. DOI: 10.3111/13696998.2015.1006366
- Watkins D, Lubinga SJ, Mayosi B, Babigumira JB. A cost-effectiveness tool to guide the prioritization of interventions for rheumatic fever and rheumatic heart disease control in African nations. PLOS Neglected Tropical Diseases. 2016; 10(8):
e0004860 . DOI: 10.1371/journal.pntd.0004860 - Nordet P, Lopez R, Duenas A, et al. Prevention and control of rheumatic fever and rheumatic heart disease: The Cuban experience (1986–1996–2002). Cardiovascular Journal of Africa. 2008.
- Quaglio G, Karapiperis T, Van Woensel L, Arnold E, McDaid D. Austerity and health in Europe. Health Policy. 2013; 113(1–2):13–9. DOI: 10.1016/j.healthpol.2013.09.005
- do Espirito Santo Freire K, de Carvalho MA, Brito TA, Menezes MS. Valve surgery: Results of the Brazilian public health system. Brazilian Journal of Medicine and Human Health. 2014; 2(2). DOI: 10.17267/2317-3386bjmhh.v2i2.421
DOI: https://doi.org/10.5334/gh.529 | Journal eISSN: 2211-8179
Language: English
Submitted on: Jul 16, 2019
Accepted on: Dec 18, 2019
Published on: Feb 20, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Jasper Ubels, Craig Sable, Andrea Z. Beaton, Maria Carmo P. Nunes, Kaciane K. B. Oliveira, Lara C. Castro, Isabella M. Teixeira, Gabriela Z. L. Ruiz, Letícia Maria M. Rabelo, Alison R. Tompsett, Antonio Luiz P. Ribeiro, Klas-Göran Sahlen, Bruno R. Nascimento, On behalf of the PROVAR+ (Programa de RastreamentO da VAlvopatia Reumática e Outras Doenças Cardiovasculares) investigators, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.